enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Intercept (ICPT) Catches Eye: Stock Jumps 8.4% - AOL

   www.aol.com/news/intercept-icpt-catches-eye...

   Intercept (ICPT) saw a big move last session, as its shares jumped more than 8% on the day, amid huge volumes.

3. Intercept Pharmaceuticals Stock Appears To Be Possible ... - AOL

   www.aol.com/news/intercept-pharmaceuticals-stock...

   The stock of Intercept Pharmaceuticals (NAS:ICPT, 30-year Financials) appears to be possible value trap, according to GuruFocus Value calculation.

4. Intercept Pharma Summarizes Key Actions in Strategic ...

   www.aol.com/news/intercept-pharma-summarizes-key...

   Intercept Pharmaceuticals Inc (NASDAQ: ICPT) announced a summary of its actions to improve its capital position, including the recently announced private repurchases of senior secured convertible ...

5. Intercept's (ICPT) Q2 Loss Narrower Than Expected, Sales Beat

   www.aol.com/news/intercepts-icpt-q2-loss...

   Intercept (ICPT) posts a narrower loss in the second quarter and sales beat estimates.

6. Intercept Pharmaceuticals - Wikipedia

   en.wikipedia.org/wiki/Intercept_Pharmaceuticals

   Intercept Pharmaceuticals, Inc. is an American biopharmaceutical company incorporated in 2002, focusing on the development of novel synthetic bile acid analogs to treat chronic liver diseases, such as primary biliary cirrhosis (PBC) now called primary biliary cholangitis, non-alcoholic fatty liver disease (or non-alcoholic steatohepatitis, NASH), cirrhosis, portal hypertension, primary ...

7. Intercept Shares Jump After Reissuing Annual Guidance - AOL

   www.aol.com/news/intercept-shares-jump-reissuing...

   Intercept Pharmaceuticals Inc (NASDAQ: ICPT) completed the sale of its international business for $405 million in upfront consideration. The company held a pre-submission meeting with FDA in July ...

8. Intercept (ICPT) Q3 Earnings Miss, Sales Beat, View Raised - AOL

   www.aol.com/news/intercept-icpt-q3-earnings-miss...

   Intercept (ICPT) posts a wider loss in Q3 due to a loss on extinguishment of debt but beats on sales. Management increases annual sales guidance.

9. Intercept's (ICPT) Stock Rises After Layoff Announcement - AOL

   www.aol.com/news/intercepts-icpt-stock-rises-lay...

   For premium support please call: 800-290-4726 more ways to reach us